Literature DB >> 20658239

Assessment of cardiac and pulmonary function in children with juvenile idiopathic arthritis.

Eman A M Alkady1, Hatem A R Helmy, Aliaë A R Mohamed-Hussein.   

Abstract

Juvenile idiopathic arthritis (JIA) is the most common rheumatologic disorder of childhood. It is a group of diseases characterized by chronic synovitis and associated with many extra-articular manifestations including cardiac and pulmonary involvement. Cardiac involvement as pericarditis, myocarditis and valvular disease is common in JIA. There are, however, few descriptions concerning systolic and diastolic functions of the left ventricle (LV) and the development of lung disease in children with JIA. The study was carried out to detect the cardiac and pulmonary involvement and to study the systolic and diastolic function of the left ventricle in a group of children with juvenile idiopathic arthritis. Forty-five children with JIA without any cardiac or pulmonary symptoms and 30 age- and sex-matched controls were included in the study. M-mode, two-dimensional and pulsed Doppler echocardiography (ECHO) was performed on 36 patients. Tissue Doppler ECHO examination was performed on 24 patients to assess systolic and diastolic functions of left ventricle. Pulmonary function tests: Forced vital capacity (FVC%), the predicted forced expiratory volume in the first second (FEV(1)%) and FEV(1)/FVC ratio and peak expiratory flow (PEF), total lung capacity (TLC) and residual volume (RV), carbon monoxide diffusing capacity of the lung (DLCO) and DLCO/alveolar volume (VA) were evaluated in 32 patients. Informed consent was obtained from all children's parents. The study protocol was approved by ethical committee of Faculty of Medicine, Assiut University. In this study, children with JIA had higher systolic and diastolic blood pressures, resting heart rate, left ventricle systolic size and volume (4.35 ± 0.68 vs. 3.92 ± 0.28, P value = 0.02). On Doppler and tissue Doppler analysis, the JIA group had lower peak early filling velocity (E, m/s), higher peak atrial filling velocity (A, m/s) and prolonged diastolic E and A waves deceleration times and isovolumic relaxation time (IRT) compared to control. Regarding pulmonary function tests, children with JIA showed significant decrease in FVC, PEF, Pimax, Pemax and DLCO compared to normal controls. This decrease was not related to age, height or weight of these patients. There was significant inverse correlation between lung function parameters and the rheumatoid factor titer, erythrosedimentation rate, disease duration and the duration of methotrexate use (P < 0.01). Despite of an asymptomatic cardiopulmonary status, significant systolic and diastolic functional abnormalities exist in children with JIA. Also, both restrictive and obstructive lung impairments were found.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658239     DOI: 10.1007/s00296-010-1548-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  30 in total

1.  Early onset of pulmonary parenchymal disease associated with juvenile rheumatoid arthritis.

Authors:  B E Noyes; G M Albers; D E deMello; B K Rubin; T L Moore
Journal:  Pediatr Pulmonol       Date:  1997-12

2.  Juvenile idiopathic arthritis.

Authors:  D Sircar; B Ghosh; Alakendu Ghosh; S Haldar
Journal:  Indian Pediatr       Date:  2006-05       Impact factor: 1.411

3.  Pulmonary fibrosis and other clinical manifestations of small vessel vasculitis in a family with seropositive juvenile rheumatoid arthritis.

Authors:  Julia Rohayem; W Leupold; K-D Paul; M Gahr
Journal:  Pediatr Pulmonol       Date:  2002-01

4.  Pulmonary function in childhood connective tissue diseases.

Authors:  I Cerveri; C Bruschi; A Ravelli; M C Zoia; F Fanfulla; L Zonta; G Pellegrini; A Martini
Journal:  Eur Respir J       Date:  1992-06       Impact factor: 16.671

5.  Cardiac manifestations in patients with HLA B27-associated juvenile arthritis.

Authors:  H Huppertz; I Voigt; J Müller-Scholden; K Sandhage
Journal:  Pediatr Cardiol       Date:  2000 Mar-Apr       Impact factor: 1.655

6.  Lung function and diffusing capacity for carbon monoxide in patients with juvenile chronic arthritis: effect of disease activity and low dose methotrexate therapy.

Authors:  A Pelucchi; C Lomater; V Gerloni; A Foresi; F Fantini; L Marazzini
Journal:  Clin Exp Rheumatol       Date:  1994 Nov-Dec       Impact factor: 4.473

Review 7.  Outcome in juvenile arthritis.

Authors:  R G Hull
Journal:  Br J Rheumatol       Date:  1988

8.  Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis.

Authors:  S Ozer; D Alehan; S Ozme; A Bakkaloğlu; O Söylemezoğlu
Journal:  Pediatr Cardiol       Date:  1994 May-Jun       Impact factor: 1.655

9.  Diastolic function abnormalities in rheumatoid arthritis: relation with duration of disease.

Authors:  N Udayakumar; S Venkatesan; C Rajendiran
Journal:  Singapore Med J       Date:  2007-06       Impact factor: 1.858

10.  Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.

Authors:  C P Appleton; L K Hatle; R L Popp
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

View more
  12 in total

Review 1.  Pulmonary capillaritis leading to alveolar hemorrhage in a juvenile idiopathic arthritis patient: first description.

Authors:  Elisa Watanabe; Leonardo Rios Diniz; Licia Maria Henrique da Mota; Solange Murta Barros; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2011-07-22       Impact factor: 2.631

2.  QT dispersion and cardiac involvement in patients with juvenile idiopathic arthritis.

Authors:  Bülent Koca; Ozgür Kasapçopur; Süleyman Bakari; Emre Celik; Ozden Calay
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

Review 3.  Cardiac involvement in juvenile idiopathic arthritis.

Authors:  Bulent Koca; Sezgin Sahin; Amra Adrovic; Kenan Barut; Ozgur Kasapcopur
Journal:  Rheumatol Int       Date:  2016-07-14       Impact factor: 2.631

4.  Use of tissue Doppler and its comparison with other pulse Doppler echocardiography in the evaluation of diastolic functions in patients with active juvenile idiopathic arthritis.

Authors:  Bülent Koca; Tevfik Demir; Özgür Kasapçopur
Journal:  Clin Rheumatol       Date:  2014-08-23       Impact factor: 2.980

5.  The forgotten chamber: right-ventricular functions in juvenile idiopathic arthritis.

Authors:  Mehtap Haktanir Abul; Muferet Erguven; Beste Ozben; Yusuf Izzet Ayhan
Journal:  Pediatr Cardiol       Date:  2012-02-17       Impact factor: 1.655

6.  HDL function and subclinical atherosclerosis in juvenile idiopathic arthritis.

Authors:  Preethi Mani; Kiyoko Uno; MyNgan Duong; Kathy Wolski; Steven Spalding; M Elaine Husni; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

7.  P wave dispersion in juvenile idiopathic arthritis patients with diastolic dysfunction.

Authors:  Bülent Koca; Süleyman Bakari; Ozgür Kasapçopur; Emre Celik; Funda Oztunç; Ayşe Güler Eroğlu; Levent Saltik
Journal:  Iran J Pediatr       Date:  2012-12       Impact factor: 0.364

8.  Assessment of left atrial mechanical functions and atrial electromechanical delay in Juvenile idiopathic arthritis by tissue Doppler echocardiography.

Authors:  Azza Z El Eraky; Nesrin M Handoka; Mona Sayed Ghaly; Samah Ismail Nasef; Nahed A Eldahshan; Ahmed M Ibrahim; Sherein Shalaby
Journal:  Pediatr Rheumatol Online J       Date:  2016-11-24       Impact factor: 3.054

Review 9.  Why is a paediatric respiratory specialist integral to the paediatric rheumatology clinic?

Authors:  Manisha Ramphul; Kathy Gallagher; Kishore Warrier; Sumit Jagani; Jayesh Mahendra Bhatt
Journal:  Breathe (Sheff)       Date:  2020-12

Review 10.  Premature subclinical atherosclerosis in children and young adults with juvenile idiopathic arthritis. A review considering preventive measures.

Authors:  Anna-Helene Bohr; Robert C Fuhlbrigge; Freddy Karup Pedersen; Sarah D de Ferranti; Klaus Müller
Journal:  Pediatr Rheumatol Online J       Date:  2016-01-06       Impact factor: 3.054

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.